innoscripta

17 Jun 2025

Founders Plan Selective Share Purchases to Support Share Price

Image for - Founders Plan Selective Share Purchases to Support Share Price

Get a summary in:

Munich, June 17, 2025 — The two primary innoscripta SE shareholders, Michael Hohenester (through Hohenester Beteiligungs-UG) and Alexander Meyer (through Meyer Beteiligungs-UG), have announced their intention to purchase a limited number of innoscripta SE shares through the stock exchange. The total volume is planned to be up to €12 million, with €10 million from Hohenester Beteiligungs-UG and €2 million from Meyer Beteiligungs-UG.

The acquired shares are subject to existing lock-up obligations and may be sold no earlier than after the respective periods following the IPO have expired. Any subsequent sale will only be considered if there is a substantial and sustained recovery in the share price compared to the IPO placement price of €120. Attention will be paid to a market-compatible increase in the free float.

This initiative is exclusively financed from the shareholders’ private funds and demonstrates their long-term confidence in innoscripta SE’s business model and prospects.

Ready to Take the Next Step?

Our experts can help you assess your eligibility, structure your R&D documentation, and maximize the benefits of the Research Allowance.

innoscripta

The data layer for R&D, a continuous, verifiable record of the work your teams actually do, captured at source. Publicly listed, ISO 27001-certified, in 20+ countries.

innoscripta provides software solutions, documentation support, and general information on R&D funding. Our services do not include individual tax, legal, or financial advice.

Eligibility, funding rates, and potential outcomes depend on the applicable laws and regulations as well as the specific circumstances of the company and the respective project. Before submitting an application, we therefore recommend seeking qualified tax, legal, or financial advice where appropriate.

For further information, please refer to our information notice.



Copyright © 2026 - innoscripta SE

Bahnhofstr. 17, 82327 Tutzing, Germany

+49 89 255 553 537

info@innoscripta.com